Compounds > dihydrotetrabenazine
Page last updated: 2024-09-03

dihydrotetrabenazine and Huntington Disease

dihydrotetrabenazine has been researched along with Huntington Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bozigian, H; Grigoriadis, DE; Loewen, G; O'Brien, CF; Skor, H; Smith, EB1
Chang, DJ; Jung, JK; Jung, JW; Kim, NJ; Moon, H; Paek, SM; Shin, D; Suh, YG1
Albin, RL; Bohnen, NI; Ficaro, E; Frey, KA; Kilbourn, MR; Koeppe, RA; Kuhl, DE; Meyer, P; Wernette, K1

Other Studies

3 other study(ies) available for dihydrotetrabenazine and Huntington Disease

ArticleYear
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine.
    Drugs in R&D, 2017, Volume: 17, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Adult; Chromatography, Liquid; Female; Humans; Huntington Disease; Isomerism; Male; Middle Aged; Tandem Mass Spectrometry; Tardive Dyskinesia; Tetrabenazine; Valine

2017
A concise total synthesis of (+)-tetrabenazine and (+)-α-dihydrotetrabenazine.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2010, Apr-19, Volume: 16, Issue:15

    Topics: Cholera; Huntington Disease; Molecular Structure; Stereoisomerism; Tetrabenazine

2010
Decreased striatal monoaminergic terminals in Huntington disease.
    Neurology, 2000, May-09, Volume: 54, Issue:9

    Topics: Adult; Aged; Brain Mapping; Corpus Striatum; Female; Humans; Huntington Disease; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Neurotransmitter Agents; Predictive Value of Tests; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2000